Prostate cancer treatment and osteoporosis risk
This article has no abstract so we have provided the first paragraph of the full text.
Insufficient attention is given to the risk of osteoporosis in men receiving androgen deprivation therapy (ADT), according to a recent study published in Cancer. Although ADT is a known risk factor for osteoporosis, few patients appear to receive the appropriate interventions for the prevention or treatment of the disease.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Breast cancer and osteolytic metastases: Can bisphosphonates help?Nature Medicine News and Views (01 Feb 1997)